English
SZABO-SCANDIC is funding Ilaria Dorigatti's research on deciphering the molecular regulatory role of an enzyme in ether lipid metabolism in the haematopoietic and lymphoid system with the Immunis 2022. It is already known from the literature that defects in related enzymes in the same metabolic pathway are the cause of the human peroxisome-related disease rhizomelic chondrodysplasia punctata (RCDP).
LifeSpan BioSciences (LSBio) provides high-quality antibodies, proteins, biochemicals, ELISA and assay kits to researchers worldwide. Founded in 1995, LSBio is a leading molecular pathology company with a focus on protein localization by IHC.
Zymo Research is a globally established biotechnology company and an industry leader in epigenetics, microbiomics and the emerging field of next-generation sequencing. With international facilities and a global distribution network, Zymo Research enables academic and biomedical researchers to make cutting-edge discoveries.
Normally, so-called coagulation factors in the plasma ensure rapid haemostasis. If these factors are missing or are only produced inadequately, this can result in excessive bleeding or even serious haemorrhages in joints or brain haemorrhages and means an increased risk during operations.
May 15th, 2024, 9:30 a.m. - 3:30 p.m.
Austria Center Vienna, hall X2
Trade fair for instrumental analysis, laboratory technology, laboratory chemicals & life science
June 13th-14th, 2024
Graz Airport, 1st floor, rooms K1 to K4
Symposium for molecular diagnostics
SZABO-SCANDIC and the Next Generation Immunologists are again launching the Immunis Sponsorship for Young Science. The research grant has already supported four young scientists in their projects. In this third round, cash and material prizes totalling 7,500 euros are available. The application deadline is June 30, 2024.
SZABO-SCANDIC proudly presents the new logo and we would like to explain what it represents. The design emphasises our commitment to the life science sector across Europe. It stands for our unified mission to provide top-tier life science products and services as well as driving progress in research and healthcare.
Established in 1997, Nordic BioSite was founded with the ambition to be the leading Nordic distribution partner of premium reagents for life science research use. Four years ago, following the successful penetration of the Nordic market, their commercial ambition was broadened to become the leading life science distributor in Europe. Nordic BioSite Group has since increased sales x5 through high organic growth and yearly best-in-class acquisitions.
The VectaPlex™ Antibody Removal Kit from Vector Laboratories is a groundbreaking innovation in life science research. It enables the simultaneous use of up to six different fluorescent dyes in a single tissue section, revolutionizing the analysis of biological samples.
Deutsch